140 related articles for article (PubMed ID: 26227563)
1. Tamoxifen Improves Final Height Prediction in Girls with McCune-Albright Syndrome: A Long Follow-Up.
de G Buff Passone C; Kuperman H; Cabral de Menezes-Filho H; Spassapan Oliveira Esteves L; Lana Obata Giroto R; Damiani D
Horm Res Paediatr; 2015; 84(3):184-9. PubMed ID: 26227563
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.
Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
Eugster EA; Rubin SD; Reiter EO; Plourde P; Jou HC; Pescovitz OH;
J Pediatr; 2003 Jul; 143(1):60-6. PubMed ID: 12915825
[TBL] [Abstract][Full Text] [Related]
4. McCune Albright Syndrome (MCAS): a case series.
Rao S; Colaco MP; Desai MP
Indian Pediatr; 2003 Jan; 40(1):29-35. PubMed ID: 12554915
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome.
Eugster EA; Shankar R; Feezle LK; Pescovitz OH
J Pediatr Endocrinol Metab; 1999; 12(5):681-6. PubMed ID: 10703542
[TBL] [Abstract][Full Text] [Related]
6. [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].
Jung AJ; Soskin S; Paris F; Lipsker D
Ann Dermatol Venereol; 2016 Jan; 143(1):21-6. PubMed ID: 26610360
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
8. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Alves C; Silva SF
J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
[TBL] [Abstract][Full Text] [Related]
9. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Roth C; Freiberg C; Zappel H; Albers N
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
[TBL] [Abstract][Full Text] [Related]
10. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
[TBL] [Abstract][Full Text] [Related]
11. McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.
Gryngarten M; Comar H; Arcari A; Boulgourdjian E; Escobar ME; Domené H
Arch Argent Pediatr; 2021 Oct; 119(5):e420-e427. PubMed ID: 34569743
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Management of Patients With McCune-Albright Syndrome With GH Excess and Precocious Puberty: A Case Series and Literature Review.
Zhai X; Duan L; Yao Y; Xing B; Deng K; Wang L; Feng F; Liang Z; You H; Yang H; Lu L; Chen S; Wang R; Pan H; Zhu H
Front Endocrinol (Lausanne); 2021; 12():672394. PubMed ID: 34777239
[TBL] [Abstract][Full Text] [Related]
13. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.
Estrada A; Boyce AM; Brillante BA; Guthrie LC; Gafni RI; Collins MT
Eur J Endocrinol; 2016 Nov; 175(5):477-483. PubMed ID: 27562402
[TBL] [Abstract][Full Text] [Related]
15. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
16. McCune-Albright syndrome.
Dumitrescu CE; Collins MT
Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
[TBL] [Abstract][Full Text] [Related]
17. Hyperthyroidism with fibrous dysplasia: an unusual presentation of McCune-Albright syndrome.
Bhat MH; Bhadada S; Dutta P; Bhansali A; Mittal BR
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):331-3. PubMed ID: 17516298
[TBL] [Abstract][Full Text] [Related]
18. A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment.
Papadopoulou M; Doula S; Kitsios K; Kaltsas T; Kosta K
Hormones (Athens); 2006; 5(3):205-9. PubMed ID: 16950755
[TBL] [Abstract][Full Text] [Related]
19. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
20. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
Völkl TM; Dörr HG
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]